Despite that the main source of FABP4 is adipose tissue (for review, see [27,42]), Fabp4 can also be expressed in livers from NAFLD [43], and has been identified as a predictive factor for poor prognosis [44]. The gene discussed is FABP4; the disease is metabolic dysfunction-associated steatotic liver disease.